The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dymista 137 micrograms / 50 micrograms per actuation, Nasal Spray Suspension

Viatris Healthcare LimitedPA23355/010/001

Main Information

Trade NameDymista 137 micrograms / 50 micrograms per actuation, Nasal Spray Suspension
Active SubstancesAzelastine hydrochloride
Fluticasone propionate
Dosage FormNasal spray, suspension
Licence HolderViatris Healthcare Limited
Licence NumberPA23355/010/001

Group Information

ATC CodeR01AD Corticosteroids
R01AD58 fluticasone, combinations


License statusAuthorised
Licence Issued22/02/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back